LSE - Delayed Quote GBp

Diaceutics PLC (DXRX.L)

121.50
0.00
(0.00%)
At close: May 9 at 3:16:21 PM GMT+1

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Mr. Peter Keeling Founder & Executive Chairman 310.99k -- 1960
Mr. Ryan Keeling CEO & Director 282.49k -- 1982
Mr. Nicholas Stewart Roberts CFO & Director 193.05k -- 1982
Ken Ruppel Vice President of Scientific & Medical Services -- -- --
Ms. Gillian Shaw General Counsel -- -- --
Amie McNiece Vice President of Marketing -- -- --
Marianna Sciortino Interim VP of Sales -- -- --
Ms. Sandra Blake Chief People Officer -- -- --
Mr. Jordan Russell Clark Chief Data Officer? & Executive Director -- -- 1984
Ms. Susanne Munksted Chief Precision Medicine Officer -- -- --

Diaceutics PLC

Building Two
First Floor Dataworks at Kings Hall Health & Wellbei
Belfast, BT9 6GW
United Kingdom
https://www.diaceutics.com
Sector: 
Healthcare
Full Time Employees: 
184

Description

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Corporate Governance

Diaceutics PLC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 13, 2025 at 7:30 AM UTC

Diaceutics PLC Earnings Date

Recent Events

Related Tickers